These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7879735)

  • 21. Comparison of gene expression profiles in HepG2 cells exposed to arsenic, cadmium, nickel, and three model carcinogens for investigating the mechanisms of metal carcinogenesis.
    Kawata K; Shimazaki R; Okabe S
    Environ Mol Mutagen; 2009 Jan; 50(1):46-59. PubMed ID: 19031421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of chromosomal damage in Chinese hamster ovary cells by soluble and particulate nickel compounds: preferential fragmentation of the heterochromatic long arm of the X-chromosome by carcinogenic crystalline NiS particles.
    Sen P; Costa M
    Cancer Res; 1985 May; 45(5):2320-5. PubMed ID: 3986775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in expression of imprinted genes following treatment of human cancer cell lines with non-mutagenic or mutagenic carcinogens.
    Shibui T; Higo Y; Tsutsui TW; Uchida M; Oshimura M; Barrett JC; Tsutsui T
    Int J Oncol; 2008 Aug; 33(2):351-60. PubMed ID: 18636156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens.
    Fukushima S; Kinoshita A; Puatanachokchai R; Kushida M; Wanibuchi H; Morimura K
    Carcinogenesis; 2005 Nov; 26(11):1835-45. PubMed ID: 15975961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic carcinogens: evaluation and risk assessment.
    Williams GM; Whysner J
    Exp Toxicol Pathol; 1996 Feb; 48(2-3):189-95. PubMed ID: 8672874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypomethylation of DNA: a nongenotoxic mechanism involved in tumor promotion.
    Counts JL; Goodman JI
    Toxicol Lett; 1995 Dec; 82-83():663-72. PubMed ID: 8597125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical and biological attributes of nickel compounds in relationship to carcinogenic activities.
    Sunderman FW
    J UOEH; 1987 Mar; 9 Suppl():84-94. PubMed ID: 3602750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nickel and epigenetic gene silencing.
    Sun H; Shamy M; Costa M
    Genes (Basel); 2013 Oct; 4(4):583-95. PubMed ID: 24705264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinogenicity assessment of selected nickel compounds.
    Oller AR; Costa M; Oberdörster G
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):152-66. PubMed ID: 9073603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that the capacity of nongenotoxic carcinogens to induce oxidative stress is subject to marked variability.
    Henderson CJ; Cameron AR; Chatham L; Stanley LA; Wolf CR
    Toxicol Sci; 2015 May; 145(1):138-48. PubMed ID: 25690736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Specificity of the interaction of carcinogenic and cytostatic agents with the elements of the genome at different levels of its organization].
    S'iakste NI; S'iakste TG
    Eksp Onkol; 1988; 10(2):3-8. PubMed ID: 3292213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nickel carcinogenesis, mutation, epigenetics, or selection.
    Costa M; Klein CB
    Environ Health Perspect; 1999 Sep; 107(9):A438-9. PubMed ID: 10464080
    [No Abstract]   [Full Text] [Related]  

  • 33. Facts and theories concerning the mechanisms of carcinogenesis.
    Pitot HC; Dragan YP
    FASEB J; 1991 Jun; 5(9):2280-6. PubMed ID: 1860619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyper-methylated miR-203 dysregulates ABL1 and contributes to the nickel-induced tumorigenesis.
    Zhang J; Zhou Y; Wu YJ; Li MJ; Wang RJ; Huang SQ; Gao RR; Ma L; Shi HJ; Zhang J
    Toxicol Lett; 2013 Oct; 223(1):42-51. PubMed ID: 23968727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens.
    French J; Storer RD; Donehower LA
    Toxicol Pathol; 2001; 29 Suppl():24-9. PubMed ID: 11695559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the localization of chromosome damage induced by calcium chromate and nickel compounds.
    Sen P; Conway K; Costa M
    Cancer Res; 1987 Apr; 47(8):2142-7. PubMed ID: 3829003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metallothionein-I/II double knockout mice are no more sensitive to the carcinogenic effects of nickel subsulfide than wild-type mice.
    Waalkes MP; Liu J; Kasprzak KS; Diwan BA
    Int J Toxicol; 2005; 24(4):215-20. PubMed ID: 16126615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinogenicity and mutagenicity of nickel and nickel compounds.
    Reith A; Brøgger A
    IARC Sci Publ; 1984; (53):175-192. PubMed ID: 6398282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preferential carcinogen-DNA adduct formation at codons 12 and 14 in the human K-ras gene and their possible mechanisms.
    Hu W; Feng Z; Tang MS
    Biochemistry; 2003 Aug; 42(33):10012-23. PubMed ID: 12924950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives on the risk assessment for nongenotoxic carcinogens and tumor promoters.
    Perera FP
    Environ Health Perspect; 1991 Aug; 94():231-5. PubMed ID: 1954932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.